药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Oxymetazoline
Sevoflurane
The risk or severity of QTc prolongation can be increased when Sevoflurane is combined with Hydroxychloroquine.
Oxymetazoline
Salbutamol
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxychloroquine.
Oxymetazoline
Inotersen
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Inotersen.
Oxymetazoline
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pipemidic acid.
Oxymetazoline
Rufloxacin
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Rufloxacin.
Oxymetazoline
Piromidic acid
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Piromidic acid.
Oxymetazoline
Lorajmine
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Lorajmine.
Oxymetazoline
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Oxolinic acid.
Oxymetazoline
Prajmaline
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Prajmaline.
Oxymetazoline
Cibenzoline
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Cibenzoline.
Oxymetazoline
Cicletanine
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Cicletanine.
Oxymetazoline
Pilsicainide
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pilsicainide.
Oxymetazoline
Givinostat
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Givinostat.
Oxymetazoline
Temefos
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Temefos.
Oxymetazoline
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Prulifloxacin.
Oxymetazoline
CUDC-907
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with CUDC-907.
Oxymetazoline
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Pazufloxacin.
Oxymetazoline
Bilastine
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Bilastine.
Oxymetazoline
Difloxacin
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Difloxacin.
Oxymetazoline
Sarafloxacin
The risk or severity of QTc prolongation can be increased when Hydroxychloroquine is combined with Sarafloxacin.